PL3325080T3 - Sposoby lepszego dostarczania środków czynnych do guzów - Google Patents
Sposoby lepszego dostarczania środków czynnych do guzówInfo
- Publication number
- PL3325080T3 PL3325080T3 PL16831139T PL16831139T PL3325080T3 PL 3325080 T3 PL3325080 T3 PL 3325080T3 PL 16831139 T PL16831139 T PL 16831139T PL 16831139 T PL16831139 T PL 16831139T PL 3325080 T3 PL3325080 T3 PL 3325080T3
- Authority
- PL
- Poland
- Prior art keywords
- tumors
- ways
- active agents
- better delivery
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0061—Methods for using microneedles
Landscapes
- Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Medical Informatics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562196578P | 2015-07-24 | 2015-07-24 | |
| US201562196570P | 2015-07-24 | 2015-07-24 | |
| PCT/US2016/043623 WO2017019526A2 (en) | 2015-07-24 | 2016-07-22 | Methods for better delivery of active agents to tumors |
| EP16831139.7A EP3325080B1 (en) | 2015-07-24 | 2016-07-22 | Methods for better delivery of active agents to tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3325080T3 true PL3325080T3 (pl) | 2022-01-24 |
Family
ID=57885141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16831139T PL3325080T3 (pl) | 2015-07-24 | 2016-07-22 | Sposoby lepszego dostarczania środków czynnych do guzów |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US10806913B2 (pl) |
| EP (2) | EP3325080B1 (pl) |
| JP (1) | JP7082041B2 (pl) |
| KR (1) | KR20180035209A (pl) |
| CN (2) | CN118902979A (pl) |
| AU (3) | AU2016297823B2 (pl) |
| BR (1) | BR112018001292A2 (pl) |
| CA (1) | CA2991455C (pl) |
| DK (1) | DK3325080T3 (pl) |
| ES (1) | ES2891523T3 (pl) |
| HU (1) | HUE056410T2 (pl) |
| MX (2) | MX2018000166A (pl) |
| PL (1) | PL3325080T3 (pl) |
| RU (1) | RU2719943C2 (pl) |
| WO (1) | WO2017019526A2 (pl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20180035209A (ko) * | 2015-07-24 | 2018-04-05 | 킴벌리-클라크 월드와이드, 인크. | 종양에 대한 활성제의 더 나은 전달 방법 |
| US10737082B2 (en) * | 2015-07-24 | 2020-08-11 | Sorrento Therapeutics, Inc. | Methods for lymphatic delivery of active agents |
| US11541015B2 (en) | 2017-05-17 | 2023-01-03 | Massachusetts Institute Of Technology | Self-righting systems, methods, and related components |
| US11207272B2 (en) | 2017-05-17 | 2021-12-28 | Massachusetts Institute Of Technology | Tissue anchoring articles |
| US11659837B2 (en) | 2017-07-10 | 2023-05-30 | Basf Se | Mixtures comprising an urease inhibitor (UI) and a nitrification inhibitor such as 2-(3,4-dimethyl-1H-pyrazol-1-yl)succinic acid (DMPSA) or 3,4-dimethyl pyrazolium glycolate (DMPG) |
| US11202903B2 (en) | 2018-05-17 | 2021-12-21 | Massachusetts Institute Of Technology | Systems for electrical stimulation |
| CA3101614A1 (en) * | 2018-05-31 | 2019-12-05 | Sorrento Therapeutics, Inc. | Drug delivery methods targeting the lymphatic system |
| US12465736B2 (en) | 2018-09-24 | 2025-11-11 | L'oreal | Device comprising microneedles for in-situ reaction of a skin |
| CN112752591A (zh) * | 2018-09-24 | 2021-05-04 | 欧莱雅 | 包含用于皮肤着色的微针的装置 |
| IL293479A (en) * | 2019-12-05 | 2022-08-01 | Sorrento Therapeutics Inc | Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic delivery device |
| CN117813128A (zh) | 2021-01-22 | 2024-04-02 | 索伦托药业有限公司 | 用于微升级淋巴递送冠状病毒疫苗的装置 |
| WO2022192594A2 (en) | 2021-03-11 | 2022-09-15 | Sorrento Therapeutics, Inc. | Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease |
| AU2022290563A1 (en) | 2021-06-09 | 2024-01-25 | Sofusa Holdings Llc | Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device |
| KR20240056524A (ko) | 2021-08-18 | 2024-04-30 | 소렌토 쎄라퓨틱스, 인코포레이티드 | 림프계를 표적화하는 치료학적 제제 |
| WO2025129128A1 (en) | 2023-12-15 | 2025-06-19 | Vivasor, Inc. | Compositions and methods for non-viral delivery of therapeutic compounds |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
| PL201222B1 (pl) * | 2000-06-01 | 2009-03-31 | Watson Pharmaceuticals | Preparat transdermalny lazoksyfenu, urządzenie do podawania lazoksyfenu, oraz zastosowanie lazoksyfenu |
| JP4383168B2 (ja) * | 2001-09-12 | 2009-12-16 | ベクトン・ディキンソン・アンド・カンパニー | マイクロ針投与デバイスおよび薬物投与デバイス |
| WO2005016401A2 (en) * | 2003-06-13 | 2005-02-24 | Becton Dickinson And Company | Improved intra-dermal delivery of biologically active agents |
| WO2005023328A2 (en) | 2003-08-26 | 2005-03-17 | Becton Dickinson And Company | Methods for intradermal delivery of therapeutics agents |
| US20070191815A1 (en) | 2004-09-13 | 2007-08-16 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
| US20070088414A1 (en) | 2005-05-25 | 2007-04-19 | Campbell Robert L | Particulate formulations for intradermal delivery of biologically active agents |
| CA2612005C (en) * | 2005-06-17 | 2013-10-29 | Georgia Tech Research Corporation | Coated microstructures and method of manufacture thereof |
| US8197435B2 (en) * | 2006-05-02 | 2012-06-12 | Emory University | Methods and devices for drug delivery to ocular tissue using microneedle |
| EP2100850A1 (en) * | 2008-03-11 | 2009-09-16 | Stichting Voor De Technische Wetenschappen | Microneedle array and a method for manufacturing microneedles |
| US8715736B2 (en) | 2009-04-30 | 2014-05-06 | Florida Agricultural And Mechanical University | Nanoparticle formulations for skin delivery |
| CN101829394B (zh) * | 2010-04-27 | 2012-08-22 | 上海交通大学 | 台阶微针阵列的制备方法 |
| CN102958556B (zh) | 2010-04-28 | 2017-02-15 | 金伯利-克拉克环球有限公司 | 细胞相互作用增强的纳米图案化医疗装置 |
| US9586044B2 (en) | 2010-04-28 | 2017-03-07 | Kimberly-Clark Worldwide, Inc. | Method for increasing the permeability of an epithelial barrier |
| EP2563450B1 (en) | 2010-04-28 | 2017-07-26 | Kimberly-Clark Worldwide, Inc. | Device for delivery of rheumatoid arthritis medication |
| WO2011135531A2 (en) | 2010-04-28 | 2011-11-03 | Kimberly-Clark Worldwide, Inc. | MEDICAL DEVICES FOR DELIVERY OF siRNA |
| US20120187814A1 (en) | 2011-01-25 | 2012-07-26 | Fryling Nicholas A | Furniture System and a Frame Assembly for a Furniture System |
| US20120245445A1 (en) * | 2011-03-21 | 2012-09-27 | Michael Darryl Black | Glucose Monitoring System |
| WO2013059343A1 (en) * | 2011-10-17 | 2013-04-25 | Massachusetts Institute Of Technology | Intracellular delivery |
| BR112014009713A2 (pt) * | 2011-10-27 | 2017-04-18 | Kimberly Clark Co | administração transdérmica de agentes bioativos de alta viscosidade |
| KR101575039B1 (ko) | 2012-07-19 | 2015-12-07 | (주)아모레퍼시픽 | 노즐 장치 및 이를 포함하는 최소 침습형 주입 장치 |
| CN104661695B (zh) * | 2012-09-13 | 2019-02-15 | 亚夫拉罕·阿米尔 | 用于皮肤改善的递送装置和方法 |
| MX375442B (es) | 2012-09-21 | 2025-03-06 | Intensity Therapeutics Inc | Un agente terapéutico y un agente mejorador de la permeación intracelular para usarse en el tratamiento de cáncer. |
| CN103157178B (zh) * | 2013-02-05 | 2014-12-31 | 北京化工大学 | 精确控制微针插入长度的印章式工具 |
| US9861801B2 (en) | 2013-02-28 | 2018-01-09 | Kimberly-Clark Worldwide, Inc. | Drug delivery device |
| RU2622605C2 (ru) | 2013-02-28 | 2017-06-16 | Кимберли-Кларк Ворлдвайд, Инк. | Устройство трансдермальной доставки лекарств |
| CN105209104A (zh) | 2013-05-23 | 2015-12-30 | 金伯利-克拉克环球有限公司 | 具有改进的开放通道横截面几何形状的微针 |
| US10376674B2 (en) * | 2014-09-15 | 2019-08-13 | Ethicon, Inc. | System and method for targeted delivery of therapeutic agents to tissue |
| US10737082B2 (en) * | 2015-07-24 | 2020-08-11 | Sorrento Therapeutics, Inc. | Methods for lymphatic delivery of active agents |
| KR20180035209A (ko) * | 2015-07-24 | 2018-04-05 | 킴벌리-클라크 월드와이드, 인크. | 종양에 대한 활성제의 더 나은 전달 방법 |
-
2016
- 2016-07-22 KR KR1020187003326A patent/KR20180035209A/ko not_active Abandoned
- 2016-07-22 DK DK16831139.7T patent/DK3325080T3/da active
- 2016-07-22 EP EP16831139.7A patent/EP3325080B1/en active Active
- 2016-07-22 BR BR112018001292A patent/BR112018001292A2/pt not_active Application Discontinuation
- 2016-07-22 EP EP21189656.8A patent/EP3925599A1/en active Pending
- 2016-07-22 MX MX2018000166A patent/MX2018000166A/es unknown
- 2016-07-22 RU RU2018104102A patent/RU2719943C2/ru active
- 2016-07-22 AU AU2016297823A patent/AU2016297823B2/en not_active Ceased
- 2016-07-22 ES ES16831139T patent/ES2891523T3/es active Active
- 2016-07-22 WO PCT/US2016/043623 patent/WO2017019526A2/en not_active Ceased
- 2016-07-22 PL PL16831139T patent/PL3325080T3/pl unknown
- 2016-07-22 CN CN202411105255.4A patent/CN118902979A/zh active Pending
- 2016-07-22 CA CA2991455A patent/CA2991455C/en active Active
- 2016-07-22 US US15/744,346 patent/US10806913B2/en active Active
- 2016-07-22 CN CN201680042970.5A patent/CN107921248A/zh active Pending
- 2016-07-22 HU HUE16831139A patent/HUE056410T2/hu unknown
- 2016-07-22 JP JP2018500406A patent/JP7082041B2/ja not_active Expired - Fee Related
-
2018
- 2018-01-08 MX MX2022014277A patent/MX2022014277A/es unknown
-
2020
- 2020-09-16 US US17/022,855 patent/US20210052871A1/en not_active Abandoned
-
2021
- 2021-01-12 AU AU2021200146A patent/AU2021200146B2/en not_active Ceased
-
2022
- 2022-11-21 AU AU2022275397A patent/AU2022275397A1/en not_active Abandoned
-
2024
- 2024-03-29 US US18/622,067 patent/US20240238570A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN107921248A (zh) | 2018-04-17 |
| EP3325080A4 (en) | 2019-04-17 |
| JP2018521755A (ja) | 2018-08-09 |
| US20180193624A1 (en) | 2018-07-12 |
| EP3925599A1 (en) | 2021-12-22 |
| MX2018000166A (es) | 2018-03-26 |
| US20240238570A1 (en) | 2024-07-18 |
| US20210052871A1 (en) | 2021-02-25 |
| AU2021200146B2 (en) | 2022-08-25 |
| BR112018001292A2 (pt) | 2018-09-11 |
| CA2991455C (en) | 2023-10-10 |
| RU2018104102A (ru) | 2019-08-27 |
| AU2022275397A1 (en) | 2023-01-05 |
| EP3325080A2 (en) | 2018-05-30 |
| RU2719943C2 (ru) | 2020-04-23 |
| US10806913B2 (en) | 2020-10-20 |
| HUE056410T2 (hu) | 2022-02-28 |
| RU2018104102A3 (pl) | 2019-11-06 |
| CA2991455A1 (en) | 2017-02-02 |
| MX2022014277A (es) | 2022-12-07 |
| EP3325080B1 (en) | 2021-09-01 |
| AU2016297823B2 (en) | 2020-10-22 |
| ES2891523T3 (es) | 2022-01-28 |
| CN118902979A (zh) | 2024-11-08 |
| KR20180035209A (ko) | 2018-04-05 |
| DK3325080T3 (da) | 2021-10-04 |
| AU2016297823A1 (en) | 2018-02-15 |
| AU2021200146A1 (en) | 2021-03-18 |
| WO2017019526A2 (en) | 2017-02-02 |
| JP7082041B2 (ja) | 2022-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2024035I2 (el) | Συνθεσεις αντισωματων για τη θεραπεια ογκων | |
| FR21C1059I1 (fr) | Compositions pharmaceutiques | |
| IL264901B (en) | Administration of kynurenine depleting enzymes for tumor therapy | |
| SI3350157T1 (sl) | Sestave za doziranje terapevtskih sredstev v celice | |
| AU2016297823B2 (en) | Methods for better delivery of active agents to tumors | |
| PL3377516T3 (pl) | Kompozycja do leczenia nowotworu | |
| HUE047477T2 (hu) | Palbociclib szilárd dózisformái | |
| ZA201506916B (en) | Microstructure array for delivery of active agents | |
| PL3297605T3 (pl) | Kompozycje farmaceutyczne do stosowania miejscowego | |
| PL3283527T3 (pl) | Leczenie skojarzone nowotworów | |
| HRP20181679T1 (hr) | Amidni spojevi za liječenje hiv | |
| PL3310904T3 (pl) | Komórkowy układ ukierunkowanego dostarczania substancji czynnej | |
| KR102494289B9 (ko) | 활성 혼합물 | |
| DK3107563T3 (da) | Glycomålrettede terapeutiske midler | |
| LT2968221T (lt) | S-ketamino hidrochlorido farmacinė kompozicija | |
| DK3234107T3 (da) | B-celler til in vivo-levering af terapeutiske midler | |
| LT2981255T (lt) | Empagliflozino terapiniai panaudojimo būdai | |
| LT3116491T (lt) | Terapiškai aktyvių junginių farmacinės kompozicijos | |
| HRP20190101T1 (hr) | Terapeutske uporabe empagliflozina | |
| PL3186244T3 (pl) | Analogi dioksolanowe urydyny w leczeniu raka | |
| MA39483A (fr) | Agents thérapeutiques cibles | |
| SI4119569T1 (sl) | Konjugirane protismiselne spojine za uporabo v terapiji | |
| HUE056424T2 (hu) | Eljárások hatóanyagoknak a nyirokrendszerbe való bejuttatására | |
| IL256206A (en) | Mct4 inhibitors for treating disease | |
| DK3363428T3 (da) | Perfusionsdoseringsform |